CorMedix CRMD and Theravance Biopharma TBPH occupy a similar niche in the market as small-cap biopharmaceutical companies working to turn promising science into sustainable revenues. Both companies, ...

Explore how oncology data season is drawing attention to Nuvation Bio, Arcus Biosciences, and smaller cancer-focused biotech ...

In this article, we will look at the 10 Best Small Cap Biotech Stocks to Buy According to Hedge Funds. On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer ...

The S&P/ASX Small Ordinaries Index (XSO) closed at 3,553.80 yesterday, up 0.087% or 3.10 points. The index has gained 4.36% over the past five days, adding 148.50 points as small-cap investor ...

The S&P/ASX Small Ordinaries Index (ASX: XSO) closed at 3,562.70, down 1.18% or 42.60 points yesterday. Despite the daily ...

The S&P/ASX Small Ordinaries Index (ASX: XSO) closed at 3,390.60, down 6.60 points or 0.19% in the latest session. The index has fallen 2.10% over the past five trading days, reflecting ongoing ...

Both Iovance Biotherapeutics IOVA and Rigel Pharmaceuticals RIGL are small-cap companies focused on the successful commercialization of their marketed products. While Iovance is a cancer biotech ...

The Russell index reset is usually seen as market plumbing. In 2026, it has become a useful signal for investors watching whether US market leadership is finally spreading beyond mega-cap technology.